OquiliaOquilia
Corporate Finance

Vital Chemtech says two independent directors resign, two appointed

Vital Chemtech Limited told the National Stock Exchange that two independent directors resigned from 3 November 2026 and its board appointed two new independent directors the same day.

Key points

  • Vital Chemtech Limited said in a filing with the National Stock Exchange that two non-executive independent directors resigned with effect from 3 November 2026.
  • The company gave 'personal reasons' for one resignation and 'professional engagements and pre-occupations' for the other; each director confirmed there were no other material reasons.
  • The board appointed two additional independent directors from the same date, each for five years, subject to shareholder approval within three months.
Oquilia Newsroom
Financial news desk covering SEBI, RBI, IRDAI, and Budget-related developments.
2 min read · 546 words
Verified SourcesSource: National Stock Exchange of India
An empty meeting room with a timber table and black chairs

Photo: Crew crew / Wikimedia Commons, CC0 1.0 (cropped). Representational image.

Vital Chemtech Limited said in a filing with the National Stock Exchange on 2 November 2026 that two of its non-executive independent directors have resigned with effect from 3 November 2026. The company said its board appointed two new independent directors from the same date. The disclosure was made after a board meeting held on 2 November 2026.

What Happened

According to the filing, the board of Vital Chemtech met at its registered office in Ahmedabad on 2 November 2026. The meeting began at 4:00 pm and ended at 5:00 pm.

The board took note of the resignation of the first independent director, effective 3 November 2026. The company said the director resigned "due to his personal reasons". It added that he confirmed there were no other material reasons for the resignation beyond those in his resignation letter, which was attached to the filing.

The board also took note of the resignation of the second independent director, effective the same date. The company said this director resigned "due to his Professional engagements and pre-occupations". He too confirmed there were no other material reasons beyond those in his letter. The filing says neither director holds a directorship in any other listed company.

On the recommendation of its Nomination and Remuneration Committee, the board appointed two additional directors in the non-executive, independent category from 3 November 2026. Each is appointed for a further term of five consecutive years and will not be liable to retire by rotation. The appointments are subject to shareholder approval at the next general meeting, or within three months, whichever is earlier.

The company said both appointees are not disqualified from being appointed under Section 164 of the Companies Act, 2013, have consented to act, and are not related to any of its directors. It also said neither is debarred from holding the office of director under any SEBI order or order of any other authority.

The same meeting approved the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, along with the limited review report of the statutory auditors.

What It Means

The exchange filing and the reasons the company gives are the public record of why the two independent directors left. The company reports the exits as resignations and quotes the reasons in the directors' own letters; it does not describe any removal.

The two new directors take office on the same date as the resignations. Their appointments still need shareholder approval at the next general meeting, or within three months, whichever is earlier. Shareholders who want the full details, including the profiles of the new directors, can read the company's filing with the National Stock Exchange.

Oquilia Data: Vital Chemtech Ltd. (NSE: VITAL)

Close, 30 Oct 2026Rs 49.99 (+1.52% on the day)
Return 1M / 3M / 6M / YTD / 1Y−7.25% / +7.39% / −17.19% / – / –
Against Nifty 50, 1M / 3M / YTD−9.17 / +12.59 / – points
Turnover, 20-session averageRs 0.02 cr; 93.2% delivered; latest volume 0.3x

Closes adjusted for splits and bonuses; returns exclude dividends. Facts from NSE's files, not investment advice.

Source: Company filing on NSE

Sources & Citations

  1. Company filing on NSE — National Stock Exchange of India

This article was last reviewed on 2 November 2026 by Oquilia's editorial team. Every claim is sourced from primary regulatory materials (CBDT, IRDAI, RBI, SEBI, Indian Kanoon). View our methodology.

Found an error? Report an issue.